In one paragraphArticle in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Manuel Collado-CuadradoZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, 37007 Salamanca, Spain.ORCID 0009-0005-8302-0449 Iván Rodríguez-EscolarZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-6009-7658 Alfonso Balmori-de la PuenteZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-9070-6709 Ana Montero-CalleChronic Disease Programme, UFIEC, Proteomics Core UCCTs, Instituto de Salud Carlos III, 28220 Madrid, Spain.ORCID 0000-0001-5141-0454 Sara Vázquez-ÁvilaReference and Research Laboratory in Parasitology, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain.
Rodrigo BarderasChronic Disease Programme, UFIEC, Proteomics Core UCCTs, Instituto de Salud Carlos III, 28220 Madrid, Spain.ORCID 0000-0003-3539-7469 Javier SotilloReference and Research Laboratory in Parasitology, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain.ORCID 0000-0002-1443-7233 Miguel PericachoDepartment of Physiology and Pharmacology, University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-0226-482X Rodrigo MorchónZoonotic Diseases and One Health Group, Faculty of Pharmacy, Centre for Environmental Studies and Rural Dynamization (CEADIR), University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-2699-1482 Funding
General Foundation of University of Salamanca art. 60 LOSUGeneral Foundation of University of Salamanca CLAVE ProgramUniversity of Salamanca-Banco Santander Predoctoral scholarship
6 · The paper itselfAbstract
Indexed as
Angiostrongylus vasorumendothelial activationin vitro modelproteomicsvascular endothelium
Identifiers
PMID41897903
PMCPMC13023303
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390